Company: ERAS
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001193125-25-103868
Chunk: 28

Company: Erasca, Inc.
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 28
---
 in a proxy statement. In addition, the stockholder must include the consent of the candidate and describe any arrangements or undertakings between the stockholder and the candidate regarding the nomination. In order to give the Nominating and Corporate Governance Committee sufficient time to evaluate a recommended candidate and include the candidate in our proxy statement for the annual meeting, the recommendation should be received by our Corporate Secretary at our principal executive offices in accordance with our procedures detailed in the section below entitled “Stockholder Proposals.” Board skills and experience Our Board comprises a diverse group of individuals with various complementary skills and business experience. We believe that our Board collectively has an appropriate mix of skills to guide and assist Erasca as we seek to achieve our long-term goals.

| Expertise                                  |     | Lim |     | Bristol |     | Casdin |     | Hambleton |     | Harding- 
 Start    |     | Liu |     | Multani |     | Varney |
| Biopharma Industry                         |     | ∎   |     | ∎       |     | ∎      |     | ∎         |     | ∎        |     | ∎   |     | ∎       |     | ∎      |
| Operational Leadership                     |     | ∎   |     | ∎       |     | ∎      |     | ∎         |     | ∎        |     | ∎   |     | ∎       |     | ∎      |
| Drug Discovery, Development and Regulatory |     | ∎   |     | ∎       |     | ∎      |     | ∎         |     | ∎        |     | ∎   |     | ∎       |     | ∎      |
| Commercial                                 |     | ∎   |     |         |     | ∎      |     |           |     |          |     | ∎   |     | ∎       |     |        |
| Financial                                  |     | ∎   |     |         |     | ∎      |     |           |     |          |     | ∎   |     |         |     |        |
| Corporate Governance                       |     | ∎   |     | ∎       |     | ∎      |     |           |     | ∎        |     | ∎   |     | ∎       |     | ∎      |

18

#### Communication from stockholders
The Board will give appropriate attention to written communications